Literature DB >> 11193176

Classification and description of frontotemporal dementias.

D Neary1, J S Snowden, D M Mann.   

Abstract

A number of distinct clinical syndromes have been described that are associated with focal degeneration of the frontal and temporal lobes and have a non-Alzheimer pathology. The nosological status of frontotemporal lobar degeneration (FTLD) has been a matter of controversy, in view of the diversity of clinical manifestations and distribution and nature of histopathological change. This paper describes the major clinical syndromes of frontotemporal dementia, progressive aphasia, and semantic dementia; it discusses their underlying pathologies and considers their molecular status. Common histopathological changes are demonstrated across the three clinical syndromes, highlighting the link between these clinical disorders. It has been suggested that these disorders should be regarded as tauopathies on the basis of the tau pathology seen in a number of cases and the mutations in the tau gene in some familial cases. However, in a series of 47 consecutive autopsy series of FTLD, only 36% had tau pathology and 10% mutations in the tau gene, suggesting that FTLD does not constitute a unitary etiological disorder and that its characterization as a tauopathy may be potentially misleading.

Entities:  

Mesh:

Year:  2000        PMID: 11193176     DOI: 10.1111/j.1749-6632.2000.tb06904.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  22 in total

1.  β-amyloid triggers ALS-associated TDP-43 pathology in AD models.

Authors:  Alexander M Herman; Preeti J Khandelwal; Brenna B Stanczyk; G William Rebeck; Charbel E-H Moussa
Journal:  Brain Res       Date:  2011-03-02       Impact factor: 3.252

2.  Let's inhibit our excitement: the relationships between Stroop, behavioral disinhibition, and the frontal lobes.

Authors:  Lara H Heflin; Victor Laluz; Jung Jang; Robin Ketelle; Bruce L Miller; Joel H Kramer
Journal:  Neuropsychology       Date:  2011-09       Impact factor: 3.295

Review 3.  The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment.

Authors:  Rawan Tarawneh; David M Holtzman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

4.  Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial.

Authors:  J B Deakin; S Rahman; P J Nestor; J R Hodges; B J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2003-12-10       Impact factor: 4.530

5.  A study of stereotypic behaviours in Alzheimer's disease and frontal and temporal variant frontotemporal dementia.

Authors:  S Nyatsanza; T Shetty; C Gregory; S Lough; K Dawson; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

Review 6.  ALS and FTLD: two faces of TDP-43 proteinopathy.

Authors:  R M Liscic; L T Grinberg; J Zidar; M A Gitcho; N J Cairns
Journal:  Eur J Neurol       Date:  2008-08       Impact factor: 6.089

7.  TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions.

Authors:  Nigel J Cairns; Manuela Neumann; Eileen H Bigio; Ida E Holm; Dirk Troost; Kimmo J Hatanpaa; Chan Foong; Charles L White; Julie A Schneider; Hans A Kretzschmar; Deborah Carter; Lisa Taylor-Reinwald; Katherine Paulsmeyer; Jeffrey Strider; Michael Gitcho; Alison M Goate; John C Morris; Manjari Mishra; Linda K Kwong; Anna Stieber; Yan Xu; Mark S Forman; John Q Trojanowski; Virginia M-Y Lee; Ian R A Mackenzie
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

8.  Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrig's disease in rats via TDP-43 overexpression.

Authors:  Jason B Tatom; David B Wang; Robert D Dayton; Omar Skalli; Michael L Hutton; Dennis W Dickson; Ronald L Klein
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

Review 9.  Neuroimaging in dementia.

Authors:  Paolo Vitali; Raffaella Migliaccio; Federica Agosta; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2008-10-08       Impact factor: 3.420

Review 10.  TDP-43 in neurodegenerative disorders.

Authors:  Casey Cook; Yong-jie Zhang; Ya-fei Xu; Dennis W Dickson; Leonard Petrucelli
Journal:  Expert Opin Biol Ther       Date:  2008-07       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.